Cardiovascular risk scores: Qualitative study of how primary care practitioners understand and use them

British Journal of General Practice

Volumn 63, Issue 611, 2013, Pages

  Liew, Su May ^a,b   Blacklock, Claire ^b   Hislop, Jenny ^b   Glasziou, Paul ^c   Mant, David ^b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c BOND UNIVERSITY   (Australia)

Author keywords

Cardiovascular diseases; Primary health care; Qualitative research; Risk assessment

Indexed keywords

ADULT; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CLINICAL PRACTICE; FEMALE; GENERAL PRACTITIONER; HUMAN; INTERVIEW; MALE; MEDICAL DECISION MAKING; PHYSICIAN ATTITUDE; PREDICTION; PRIMARY MEDICAL CARE; QUALITATIVE RESEARCH; RISK ASSESSMENT; RISK MANAGEMENT; THEMATIC ANALYSIS;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CARDIOVASCULAR DISEASES; ENGLAND; FEMALE; GENERAL PRACTITIONERS; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRIMARY PREVENTION; QUALITATIVE RESEARCH; RISK FACTORS;

EID: 84878448445     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp13X668195     Document Type: Article

References (20)

1. British Medical Association. Quality and Outcomes Framework guidance for GMS contract 2011/12. Delivering investment in general practice. London: BMA, 2011. http://www.nhsemployers.org/SiteCollectionDocuments/ QOFguidanceGMScontract-2011-12-FL%2013042011.pdf (accessed 26 Apr 2013).
2. National Institute for Health and Clinical Excellence. Lipid modification. CG67. London: NICE, 2012. http://guidance.nice.org.uk/CG67/ NICEGuidance/pdf/English (accessed 16 Apr 2013).
3. Hippisley-Cox J, Coupland C, Robson J, Brindle P. Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database. BMJ 2010; 341: c6624.
4. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008; 336(7659): 1475-;1482.
5. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007; 335(7611): 136.
6. Anekwe L. GP switch to lifetime risk on NICE agenda. Pulse 2011; 23 Aug: http://www.pulsetoday.co.uk/newsarticle-content/-/article-display-list/12581893/ gp-switch-to-lifetime-risk-on-nice-Agenda (accessed 16 Apr 2013).
7. Brindle PM, McConnachie A, Upton MN, et al. The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study. Br J Gen Pract 2005; 55(520): 838-;845.
8. Guest G, Bunce A, Johnson L. How many interviews are enough? Field Methods 2006; 18(1): 59-;82.
9. Ziebland S, McPherson A. Making sense of qualitative data analysis: an introduction with illustrations from DIPEx (personal experiences of health and illness). Med Educ 2006; 40(5): 405-;414.
10. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association. Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. BMJ 2000; 320(7236): 705-;708.
11. British National Formulary 2012 (volume 63). Cardiovascular risk prediction charts. http://www.medicinescomplete.com/mc/bnf/current/204016.htm (accessed 16 Apr 2013).
12. Hobbs FDR, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract 2002; 19(6): 596-;604.
13. Graham IM, Stewart M, Hertog MG; Cardiovascular Round Table Task Force. Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology. Eur J Cardiovasc Prev Rehabil 2006; 13(5): 839-;845.
14. Sposito AC, Ramires JA, Jukema JW, et al. Physicians' attitudes and adherence to use of risk scores for primary prevention of cardiovascular disease: cross-sectional survey in three world regions. Curr Med Res Opin 2009; 25(5): 1171-;1178.
15. Dallongeville J, Banegas JR, Tubach F, et al. Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study. Eur J Prev Cardiol 2011; 19(3): 541-;550.
16. van Steenkiste B, van der Weijden T, Stoffers HE, Grol R. Barriers to implementing cardiovascular risk tables in routine general practice. Scand J Prim Health Care 2004; 22(1): 32-;37.
17. Torley D, Zwar N, Comino EJ, Harris M. GPs' views of absolute cardiovascular risk and its role in primary prevention. Aust Fam Physician 2005; 34(6): 503-;4, 507.
18. Kirby M, Machen I. Impact on clinical practice of the Joint British Societies' cardiovascular risk assessment tools. Int J Clin Pract 2009; 63(12): 1683-;1692.
19. Müller-Riemenschneider F, Holmberg C, Rieckmann N, et al. Barriers to routine risk-score use for healthy primary care patients: survey and qualitative study. Arch Intern Med 2010; 170(8): 719-;724.
20. Wald DS, Wald NJ. The Polypill in the prevention of cardiovascular disease. Prev Med 2011; 52(1): 16-;17.